Suggestions
Rich Horgan
Founder & President, Cure Rare Disease - Forbes 30 Under 30 Healthcare - Pharmaceutical Innovation Speaker
Professional Background
Rich Horgan is a dedicated biotechnology entrepreneur and founder who is passionate about reshaping the future of rare disease drug development. With a vision of ensuring that patients today can access the cures of tomorrow, Rich has committed his career to building agile organizations that pioneer the development of next-generation customized therapeutics. As the Founder and President of Cure Rare Disease, he leads initiatives aimed at advocating for patients suffering from rare diseases, particularly Duchenne Muscular Dystrophy (Duchenne). His mission revolves around rallying an army of compassionate movers and shakers who share a resolve to challenge the status quo and create lasting change.
Prior to his role at Cure Rare Disease, Rich gained invaluable experience in business development and management through various prestigious positions. Notably, he served as a Blavatnik Fellow at Harvard Business School and worked in business development at Pison, contributing to the intersection of biotechnology and innovative business strategies. His rich career history has also included roles at Corning Incorporated, where he honed his skills as a New Business Development Analyst and M&A Analyst, delving into strategic growth initiatives within a Fortune 500 company.
Education and Achievements
Rich brings a formidable academic background to his work in biotechnology. He earned his Master of Business Administration (MBA) from Harvard Business School, where he further enhanced his business acumen and leadership skills. His undergraduate education led him to Cornell University, where he obtained a Bachelor of Science in Applied Economics and Management with a dual focus on Finance and Strategy, graduating Summa Cum Laude—an accolade that underscores his exceptional academic prowess.
Additionally, Rich participated in the prestigious Summer Venture in Management Program at Harvard Business School, gaining essential insights into entrepreneurial management. This education was foundational in shaping his approach to building impactful and agile organizations in the biotech space.
Notable Achievements
Rich's commitment to advancing treatment options for rare diseases has been a hallmark of his career. Leading Cure Rare Disease, he has been instrumental in advocating for patient-centered drug development, striving to ensure that innovative therapies are accessible to those in dire need. His leadership and vision have positioned Cure Rare Disease as a beacon of hope for many families grappling with the challenges of rare diseases.
Rich's efforts extend beyond his immediate organization, as he frequently engages in speaking engagements aimed at raising awareness about the importance of rare disease research and advocacy. He is available for paid consulting, where he shares his insights on the intricacies of biotechnology, drug development, and strategic business management.
tags([
